TEKMIRA PHARMACEUTICALS 13G

Company

Arbutus Biopharma Corp

Filed

February 14, 2011

Accession Number

0001072613-11-000203

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →